The University of Chicago Header Logo

Connection

Thinle Chodon to Drug Resistance, Neoplasm

Back to Details
This is a "connection" page, showing publications Thinle Chodon has written about Drug Resistance, Neoplasm.
Thinle Chodon
Connection Strength
0.270
Drug Resistance, Neoplasm
  1. Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy. Cancer Discov. 2014 Jan; 4(1):80-93.
    View in: PubMed
    Score: 0.091
  2. Melanoma whole-exome sequencing identifies (V600E)B-RAF amplification-mediated acquired B-RAF inhibitor resistance. Nat Commun. 2012 Mar 06; 3:724.
    View in: PubMed
    Score: 0.081
  3. Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation. Nature. 2010 Dec 16; 468(7326):973-7.
    View in: PubMed
    Score: 0.074
  4. Effects of MAPK and PI3K pathways on PD-L1 expression in melanoma. Clin Cancer Res. 2014 Jul 01; 20(13):3446-57.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.